[FG] Mahfoud Felix

Dugar, Franja et al. (2026) ‘Diagnostic and prognostic utility of endocan in suspected myocardial infarction: an international cohort study’, Clinica Chimica Acta, 578. Available at: https://doi.org/10.1016/j.cca.2025.120510.

Schlaich, M.P. et al. (2025) ‘Renal Denervation in Patients With Moderate to Severe Chronic Kidney Disease’, 82. Available at: https://doi.org/10.1161/hypertensionaha.125.25470.

Meier, Vincent et al. (2025) ‘Adverse Outcomes in Patients with Atrial Fibrillation and a Pacemaker: A Cohort Study’, Europace [Preprint]. 28.10.2025. Available at: https://doi.org/10.1093/europace/euaf275.

Runge, Florine et al. (2025) ‘Feasibility and accuracy of wearable electrocardiogram monitoring in adult congenital heart disease’, Europace, 27(10). Available at: https://doi.org/10.1093/europace/euaf247.

Mahfoud, F. et al. (2025) ‘Left Atrial Appendage Occlusion Using a Novel System’, JACC: Cardiovascular Interventions [Preprint]. Available at: https://doi.org/10.1016/j.jcin.2025.10.002.

van den Born, B.-J.H. et al. (2025) ‘Targets for Treatment and Optimal Strategies for Non-Pharmacological and Pharmacological Management of Hypertension’, European Journal of Preventive Cardiology [Preprint]. Available at: https://doi.org/10.1093/eurjpc/zwaf610.

Mair, J. et al. (2025) ‘Best of cardiovascular biomarkers’, European Heart Journal: Acute Cardiovascular Care [Preprint]. Available at: https://doi.org/10.1093/ehjacc/zuaf120.

Taggart, C. et al. (2025) ‘The assessment and management of patients with type 2 myocardial infarction: an international Delphi study’, European Heart Journal - Quality of Care and Clinical Outcomes [Preprint]. Available at: https://doi.org/10.1093/ehjqcco/qcaf069.

Frey, Simon M. et al. (2025) ‘Evaluation of the 2024 European Society of Cardiology risk-factor and calcium score-weighted clinical likelihoods as gatekeeper for patients with suspected chronic coronary syndrome referred for PET’, European Heart Journal. 05.11.2025. Oxford University Press, 46(Suppl. 1). Available at: https://doi.org/10.1093/eurheartj/ehaf784.307.

Frey, Simon M. et al. (2025) ‘Comparison of the 2024 ESC risk-factor clinical likelihood model and an artificial intelligence-based tool for ischemia detection in patients with suspected chronic coronary syndrome referred for PET’, European Heart Journal. 05.11.2025. Oxford University Press, 46(Suppl. 1). Available at: https://doi.org/10.1093/eurheartj/ehaf784.1692.

Reichl, Jakob J. et al. (2025) ‘Association of Body Mass Index With Procedural Success and Outcomes in Patients undergoing Transcatheter Aortic Valve Implantation’, American Journal of Cardiology, 248, pp. 67–72. Available at: https://doi.org/10.1016/j.amjcard.2025.04.012.

Ochoa‐Espinosa, Amanda et al. (2025) ‘Coronin 1 deficiency protects from the development of autoimmune myocarditis by reducing CD4+ T cells’, ESC Heart Failure, pp. 3524–3536. Available at: https://doi.org/10.1002/ehf2.15384.

Bima, Paolo et al. (2025) ‘Derivation and Validation of ESC-0/1-h Algorithm for High-Sensitivity Troponin T and I in Cancer Patients’, JACC: Advances, 4. Available at: https://doi.org/10.1016/j.jacadv.2025.101821.

Stolte, T. et al. (2025) ‘Non-Invasive Hemodynamic Monitoring in Transcatheter Aortic Valve Implantation’, Journal of Clinical Medicine, 14(11), p. 3794. Available at: https://doi.org/10.3390/jcm14113794.

Moretti, Enrico et al. (2025) ‘Takotsubo Syndrome and Spontaneous Coronary Artery Dissection’, Jacc Case Reports, 30(9). Available at: https://doi.org/10.1016/j.jaccas.2025.103300.

Taggart, C. et al. (2025) ‘Targeting Investigation and Treatment in Type 2 Myocardial Infarction: A Pilot Randomized Controlled Trial’, 4. Available at: https://doi.org/10.1016/j.jacadv.2025.101738.

Pfenniger, Anna et al. (2025) ‘Comparison of invasive and non-invasive gradients before and after TAVI and their implications on clinical outcomes’, Cardiovascular Intervention and Therapeutics. 19.12.2024, 40(2), pp. 362–377. Available at: https://doi.org/10.1007/s12928-024-01074-6.

Lee, J.A. et al. (2025) ‘Insulin-like growth factor binding protein-3 (IGFBP-3): a biomarker of coronary artery disease induced myocardial ischaemia’, 5. Available at: https://doi.org/10.1093/ehjopen/oeaf028.

Reichl, Jakob J. et al. (2025) ‘Prognostic impact of atrial fibrillation in patients undergoing transcatheter aortic valve implantation’, Heart Rhythm O2, 6(3), pp. 273–279. Available at: https://doi.org/10.1016/j.hroo.2024.12.016.

Wagener, Max, Boeddinghaus, Jasper and Leibundgut, Gregor (2025) ‘When 3 Fundamentals of Disaster Meet During Elective PCI’, JACC: Case Reports, 30(3), p. 103126. Available at: https://doi.org/10.1016/j.jaccas.2024.103126.

Lauder, L. et al. (2025) ‘Debate on the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: New Blood Pressure Targets, Lower Is Better - And Possible’, Hypertension [Preprint]. Available at: https://doi.org/10.1161/hypertensionaha.125.25466.

Rubini Giménez, María et al. (2025) ‘Consecuencias clínicas de los límites superiores de referencia ajustados al sexo de la troponina cardiaca I ultrasensible en el diagnóstico del infarto agudo de miocardio Clinical implications of sex-specific upper reference limits for high-sensitivity cardiac troponin I in myocardial infarction diagnosis’, Revista Espanola de Cardiologia. 23.07.2025, 78(12), pp. 1064–1075. Available at: https://doi.org/10.1016/j.recesp.2025.05.001.